{
  "ticker": "IDXX",
  "company_name": "IDEXX Laboratories, Inc.",
  "sector": "Healthcare",
  "industry": "Diagnostics & Research",
  "analysis_date": "2025-12-18",
  "business_quality_score": 10,
  "financial_health_score": 4.8,
  "valuation_score": 3,
  "growth_score": 9.8,
  "sentiment_score": 7,
  "institutional_score": 10,
  "risk_score": 8.1,
  "conviction_score": 74.0,
  "conviction_tier": "MEDIUM",
  "bull_case": "Quality healthcare company with high quality business, solid growth",
  "bear_case": "Expensive valuation",
  "market_cap": 55771271168,
  "pe_ratio": 55.36934,
  "debt_to_equity": 71.29,
  "profit_margin": 0.24654,
  "revenue_growth": 0.133,
  "current_price": 697.1,
  "analyst_target": 766.0,
  "recommendation": "buy",
  "position_size_modifier": 1.24
}